(Q40487519)

21 September 2017

Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy (English)

1 reference

21 September 2017

Nomura K

1

1 reference

21 September 2017

Kawasugi K

series ordinal

2

1 reference

21 September 2017

Morimoto T

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

European Journal of Cancer Care

21 September 2017

1 reference

21 September 2017

15

1 reference

21 September 2017

1

1 reference

21 September 2017

44-50

1 reference

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Optimal strategy for the first episode of primary spontaneous pneumothorax in young men. A decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2005.00618.X

10.1111/J.1365-2354.2005.00618.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference